Bullish Case: VKTX holds $1.8B+ cash and dual subQ/oral VK2735 late-stage assets; the 23% two-month drawdown to $28.99 has already priced delays. Helium's density shows mass concentrated at $29-32 with upside weight to $35+, and Jan 2027 call skew (100-120C at 116-123% IV) signals residual takeout/re-rating optionality. Any positive Phase 3 or maintenance-dosing data could compress the 150% front IV and rebound the stock.

Bearish Case: Backwardated term structure (153% Sept vs 98% May-2027 IV), put volume 86% above calls, and bearish risk exceeding bullish by 11% all flag imminent downside. Helium AI forecast is -0.66% with only 0.1 correlation, price is -57.5% from two years ago, and Polymarket acquisition odds collapsed to 13%. A disappointing readout or slipped timeline crushes IV and price toward $22-25.

Potential Outcomes:

1. 30% — Continued drift lower on catalyst fatigue: $25-28 by Nov (put flow + backwardation).
2. 25% — Flat consolidation $27-32; heavy Oct 16 $20-25P volume absorbs (flat Helium/market PDF overlap at $29-31).
3. 20% — Negative VK2735 data/safety shock: -30%+ toward $20 (justifies 153% front IV).
4. 15% — Positive Phase 3/maintenance readout: +20-35% to $35-40 (mid-strike call open interest).
5. 10% — Acquisition bid emerges; Polymarket 13% is stale-low given cash-rich obesity asset.

September 19, 2026